Drug Shortage Report for PHENYTOIN SODIUM INJECTION USP

Last updated on 2021-01-20 History
Report ID 130361
Drug Identification Number 02431378
Brand name PHENYTOIN SODIUM INJECTION, USP
Common or Proper name PHENYTOIN SODIUM INJECTION, USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PHENYTOIN SODIUM
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 25 VIALS 5 ML
ATC code N03AB
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-12-17
Estimated end date 2021-01-18
Actual end date 2021-01-18
Shortage status Resolved
Updated date 2021-01-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-01-20 French Compare
v6 2021-01-20 English Compare
v5 2021-01-13 French Compare
v4 2021-01-13 English Compare
v3 2020-12-18 English Compare
v2 2020-12-17 French Compare
v1 2020-12-17 English Compare

Showing 1 to 7 of 7